Sir David Cuthbertson prize medal lecture: Metabolic abnormalities and wasting in human immunodeficiency virus infection

Proceedings of the Nutrition Society

Volumn 57, Issue 3, 1998, Pages 373-380

  Macallan, Derek C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENERGY METABOLISM; HUMAN; METABOLISM; PROTEIN INTAKE; REVIEW; WASTING SYNDROME;

DIETARY PROTEINS; ENERGY METABOLISM; HIV WASTING SYNDROME; HUMANS;

EID: 0032130880     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/pns19980054     Document Type: Article

References (37)

1. Berneis K, Leisibach A, Tietz A, Bassatti S, Battegay M & Keller U (1997) Whole body protein turnover in HIV-infected patients. Nutrition 13, 269 Abstr.
2. Cuthbertson DP (1930) The disturbance of metabolism produced by bony and non-bony injury, with notes on certain abnormal conditions of bone. Biochemical Journal 24, 1244-1263.
3. Cuthbertson DP (1932) Observations on disturbance of metabolism produced by injury to the limbs. Quarterly Journal of Medicine 1, 233-246.
4. Cuthbertson DP (1942) Post-shock metabolic response. Lancet i, 433-436.
5. Cuthbertson DP (1954) Interrelationship of metabolic changes consequent to injury. British Medical Bulletin 10, 33-37.
6. Garlick PJ, Clugston GA, Swick RW & Waterlow JC (1980) Diurnal pattern of protein and energy metabolism in man. American Journal of Clinical Nutrition 33, 1983-1986.
7. Grunfeld C, Kotler DP, Hamadeh R, Tierney AR, Wang J & Pierson RN (1989) Hypertriglyceridemia in the Acquired Immunodeficiency Syndrome. American Journal of Medicine 86, 27-31.
8. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P & Feingold KR (1992a) Lipids, lipoproteins, triglyceride clearance, and cytokines in Human Immunodeficiency Virus infection and the Acquired Immunodeficiency Syndrome. Journal of Clinical Endocrinology and Metabolism 74, 1045-1052.
9. Grunfeld C, Pang M, Shigenaga JK, Jensen P, Lallone R, Friedman J & Feingold KR (1996) Serum leptin levels in the Acquired Immunodeficiency Syndrome. Journal of Clinical Endocrinology and Metabolism 81, 4342-4346.
10. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P & Feingold KR (1992b) Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. American Journal of Clinical Nutrition 55, 455-460.
11. Hellerstein MK, Grunfeld C, Wu K, Christiansen M, Kaempfer S, Kletke C & Shackleton CHL (1993) Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism 76, 559-565.
12. Hommes MJT, Romijn JA, Endert E & Sauerwein HP (1991a) Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. American Journal of Clinical Nutrition 54, 311-315.
13. Hommes MJT, Romijn JA, Endert E, Schattenkerk JKME & Sauerwein HP (1991b) Insulin sensitivity and insulin clearance in Human Immunodeficiency Virus-infected men. Metabolism 40, 651-656.
14. Hommes MJT, Romijn JA, Godfried MH, Schattenkerk JKME, Buurman WA, Endert E & Sauerwein HP (1990) Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism 39, 1186-1190.
15. Kotler DP, Tierney AR, Brenner SK, Couture S, Wang J & Pierson RN (1990) Preservation of short-term energy balance in clinically stable patients with AIDS. American Journal of Clinical Nutrition 51, 7-13.
16. Lieberman SA, Butterfield GE, Harrison D & Hoffman AR (1994) Anabolic effects of recombinant Insulin-like Growth Factor-I in cachectic patients with the Acquired Immunodeficiency Syndrome. Journal of Clinical Endocrinology and Metabolism 78, 404-410.
17. Macallan DC, McNurlan MA, Kurpad AV, De Souza G, Shetty PS, Calder AG & Griffin GE (1998) Whole body protein metabolism in human pulmonary tuberculosis and undernutrition: Evidence for anabolic block in tuberculosis. Clinical Science 94, 321-331.
18. Macallan DC, McNurlan MA, Milne E, Calder AG, Garlick PJ & Griffin GE (1995a) Whole body protein turnover from leucine kinetics and the response to nutrition in Human Immunodeficiency Virus infection. American Journal of Clinical Nutrition 61, 818-826.
19. Macallan DC, Noble C, Baldwin C, Foskett M, McManus T & Griffin GE (1993) Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. American Journal of Clinical Nutrition 58, 417-424.
20. Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA, Sawyer MB, McManus TJ & Griffin GE (1995b) Energy expenditure and wasting in Human Immunodeficiency Virus infection. New England Journal of Medicine 333, 83-88.
21. McNurlan MA, Garlick PJ, Steigbigel RT, DeCristofaro KA, Frost RA, Lang CH, Johnson RW, Santasier AM, Cabahug CJ, Fuhrer J & Gelato MC (1997) Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease. Journal of Clinical Investigation 100, 2125-2132.
22. Melchior JC, Raguin G, Boulier A, Bouvet E, Rigaud D, Matheron S, Casalino E, Vilde JL, Vachon F, Couland JP & Apfelbaum M (1993) Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections. American Journal of Clinical Nutrition 57, 614-619.
23. Melchior JC, Salmon D, Rigaud D, Leport C, Bouvet E, Detruchis P, Vilde J, Vachon F, Couland J & Apfelbaum M (1991) Resting energy expenditure is increased in stable, malnourished HIV-infected patients. American Journal of Clinical Nutrition 53, 437-441.
24. Melville S, McNurlan MA, McHardy KC, Broom J, Milne E, Calder AG & Garlick PJ (1989) The role of degradation in the acute control of protein balance in adult man; Failure of feeding to stimulate protein synthesis as assessed by 1-13C leucine infusion. Metabolism 38, 248-255.
25. Paton NIJ, Angus B, Simpson A, Calder AG, Milne E, Chaowagul W, Newton P, Suputtamongkol Y, White NJ & Griffin GE (1997a) Protein metabolism in melioidosis. Transactions of the Royal Society for Tropical Medicine and Hygiene 91, 500 Abstr.
26. Paton NIJ, Newton P, Ross H, Cotton J, Calder AG, Milne E, Sharpstone D, Macallan DC, Gazzard B & Griffin GE (1997b) Growth hormone therapy during acute opportunistic infections in AIDS has a protein-sparing effect. Proceedings of 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, vol. 1, p. 246 Abstr.
27. Paton NIJ, Newton PJ, Sharpstone DR, Ross HM, Cotton J, Calder AG, Milne E, Elia M, Shah S, Macallan DC, Gazzard BG & Griffin GE (1998) Short-term growth hormone administration at the time of opportunistic infections in HIV-positive patients. New England Journal of Medicine (In the Press).
28. Rakotoambinia B, Raynaud JJ, Melchior JC, Crenn P, Thuillier F & Messing B (1996) Whole body protein turnover assessed with leucine and glutamine kinetics in vivo at an early stage of human immunodeficiency virus infection. Clinical Nutrition 15, Suppl. 1, 13 Abstr.
29. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA & Breitmeyer JB (1996) Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Annals of Internal Medicine 125, 873-882.
30. Schwenk A, Hoffer-Belitz E, Jung B, Kremer G, Burger B, Salzberger B, Diehl V & Schrappe M (1996) Resting energy expenditure, weight loss and altered body composition in HIV infection. Nutrition 12, 595-601.
31. Serwadda D, Sewankambo NK, Carswell JW, Bayley AC, Tedder RS, Weiss RA, Mugerwa RD, Lwegaba A, Kirya GB, Downing RG, Clayden SA & Dalgleish AG (1985) Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet ii, 849-852.
32. Sharpstone DR, Murray CP, Ross HM, Hancock MR, Phelan MS, Crane RC, Menzies IS, Reaveley DA, Lepri AC, Nelson MR & Gazzard BG (1996) Energy balance in asymptomatic HIV infection. AIDS 10, 1377-1384.
33. Sheehan LA, Macallan DC & Griffin GE (1998) Determinants of energy intake and energy expenditure in HIV and AIDS. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology (In the Press).
34. Stein TP, Nutinsky C, Condoluci D, Schluter MD & Leskiw MJ (1990) Protein and energy substrate metabolism in AIDS patients. Metabolism 39, 876-881.
35. Streat SJ, Beddoe AH & Hill GL (1987) Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. Journal of Trauma 27, 262-266.
36. Suttmann U, Ockenga J, Hoogestraat L, Selberg O, Schedel I, Deicher H & Muller MJ (1993) Resting energy expenditure and weight loss in human immunodeficiency virus-infected patients. Metabolism 42, 1173-1179.
37. Teixeira A, Leu JC, Honderlick P, Trylesinski A & Zucman D (1997) Variation in body weight and plasma viral load in HIV patients treated with tritherapy including a protease inhibitor. Nutrition 13, 269 Abstr.